Beneficial metabolic effects of nateglinide versus acarbose in patients with newly-diagnosed type 2 diabetes

被引：0
作者：
Hong-wei Gao
Chao Xie
Hai-ning Wang
Yu-jing Lin
Tian-pei Hong
机构：
[1] Peking University Third Hospital,Department of Endocrinology
来源：
Acta Pharmacologica Sinica | 2007年 / 28卷
关键词：
nateglinide; acarbose; free fatty acids; asymmetric dimethylarginine;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：534 / 539
页数：5
相关论文
共 50 条
[31]   Effects of changeover from voglibose to acarbose on postprandial triglycerides in type 2 diabetes mellitus patients [J].
Matsumura, Mihoko ;
Monden, Tsuyoshi ;
Miyashita, Yasushi ;
Kawagoe, Yoshiaki ;
Shimizu, Hiroaki ;
Nakatani, Yuki ;
Domeki, Nozomi ;
Yanagi, Kazunori ;
Ikeda, Shiori ;
Kasai, Kikuo .
ADVANCES IN THERAPY, 2009, 26 (06) :660-666
[32]   Effects of changeover from voglibose to acarbose on postprandial triglycerides in type 2 diabetes mellitus patients [J].
Mihoko Matsumura ;
Tsuyoshi Monden ;
Yasushi Miyashita ;
Yoshiaki Kawagoe ;
Hiroaki Shimizu ;
Yuki Nakatani ;
Nozomi Domeki ;
Kazunori Yanagi ;
Shiori Ikeda ;
Kikuo Kasai .
Advances in Therapy, 2009, 26 :660-666
[33]   Effects of nateglinide and glibenclamide on postprandial lipid and glucose metabolism in type 2 diabetes [J].
Vakkilainen, J ;
Mero, N ;
Schweizer, A ;
Foley, JE ;
Taskinen, MR .
DIABETES-METABOLISM RESEARCH AND REVIEWS, 2002, 18 (06) :484-490
[34]   Effects of nateglinide on the secretion of glycated insulin and glucose tolerance in type 2 diabetes [J].
Lindsay, JR ;
McKillop, AM ;
Mooney, MH ;
O'Harte, FPM ;
Flatt, PR ;
Bell, PM .
DIABETES RESEARCH AND CLINICAL PRACTICE, 2003, 61 (03) :167-173
[35]   Will acarbose improve the metabolic abnormalities of insulin-resistant type 2 diabetes mellitus? [J].
Scott, R ;
Lintott, CJ ;
Zimmet, P ;
Campbell, L ;
Bowen, K ;
Welborn, T .
DIABETES RESEARCH AND CLINICAL PRACTICE, 1999, 43 (03) :179-185
[36]   Nateglinide - current and future role in the treatment of patients with type 2 diabetes mellitus [J].
Campbell, IW .
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2005, 59 (10) :1218-1228
[37]   Dementia Risk in Type 2 Diabetes Patients: Acarbose Use and Its Joint Effects with Metformin and Pioglitazone [J].
Tseng, Chin-Hsiao .
AGING AND DISEASE, 2020, 11 (03) :658-667
[38]   Single-dose acarbose decreased glucose-dependent insulinotropic peptide and glucagon levels in Chinese patients with newly diagnosed type 2 diabetes mellitus after a mixed meal [J].
Zhong Chen ;
Xiaoying Fu ;
Jian Kuang ;
Ju Chen ;
Hongmei Chen ;
Jianhao Pei ;
Huazhang Yang .
BMC Endocrine Disorders, 16
[39]   Single-dose acarbose decreased glucose-dependent insulinotropic peptide and glucagon levels in Chinese patients with newly diagnosed type 2 diabetes mellitus after a mixed meal [J].
Chen, Zhong ;
Fu, Xiaoying ;
Kuang, Jian ;
Chen, Ju ;
Chen, Hongmei ;
Pei, Jianhao ;
Yang, Huazhang .
BMC ENDOCRINE DISORDERS, 2016, 16
[40]   Acarbose diminishes postprandial suppression of bone resorption in patients with type 2 diabetes [J].
Dalsgaard, Niels B. ;
Gasbjerg, Laerke S. ;
Helsted, Mads M. ;
Hansen, Laura S. ;
Hansen, Nina L. ;
Skov-Jeppesen, Kirsa ;
Hartmann, Bolette ;
Holst, Jens J. ;
Vilsboll, Tina ;
Knop, Filip K. .
BONE, 2023, 170
12345